Growth Metrics

Theravance Biopharma (TBPH) EPS (Basic) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.31%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -79.34%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 61.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,207.14%
10 Theravance Biopharma 823.54 Mn 428.87 Mn - 62.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 62.96%
Dec 31, 2025 487.10%
Sep 30, 2025 126.92%
Jun 30, 2025 420.59%
Mar 31, 2025 -12.50%
Dec 31, 2024 -82.35%
Sep 30, 2024 -52.94%
Jun 30, 2024 -21.43%
Mar 31, 2024 31.43%
Dec 31, 2023 -13.33%
Sep 30, 2023 19.05%
Jun 30, 2023 20.00%
Mar 31, 2023 36.36%
Dec 31, 2022 80.77%
Sep 30, 2022 56.25%
Jun 30, 2022 64.65%
Mar 31, 2022 55.65%
Dec 31, 2021 15.22%
Sep 30, 2021 58.62%
Jun 30, 2021 1.00%
Mar 31, 2021 11.43%
Dec 31, 2020 21.37%
Sep 30, 2020 -10.48%
Jun 30, 2020 -38.89%
Mar 31, 2020 -6.06%
Dec 31, 2019 -27.17%
Sep 30, 2019 4.55%
Jun 30, 2019 5.26%
Mar 31, 2019 -8.20%
Dec 31, 2018 43.90%
Sep 30, 2018 13.39%
Jun 30, 2018 40.16%
Mar 31, 2018 3.94%
Dec 31, 2017 -20.59%
Sep 30, 2017 -73.97%
Jun 30, 2017 -19.81%
Mar 31, 2017 -15.45%
Dec 31, 2016 -10.57%
Sep 30, 2016 47.86%
Jun 30, 2016 25.35%
Mar 31, 2016 14.73%
Dec 31, 2015 39.11%
Sep 30, 2015 18.60%
Jun 30, 2015 22.40%
Mar 31, 2015 31.75%
Dec 31, 2014 -45.32%
Sep 30, 2014 -33.33%
Jun 30, 2014 -48.78%
Mar 31, 2014 -87.13%